Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Phase
1.1.2. Type
1.1.3. Test Type
1.1.4. Therapeutic Areas
1.1.5. End User
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.1.1. Increasing focus on the analytical testing
3.3.1.2. Growing R & D expenditure in the pharmaceutical and biopharmaceutical industries
3.3.1.3. Rising demand for outsourcing of analytical testing
3.3.2. Market restraint analysis
3.3.2.1. Compliance issues while outsourcing
3.4. Large Molecule Bioanalytical Testing Services Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.2. PESTEL Analysis
3.4.3. Market Entry Strategies
3.5. COVID – 19 Impact Analysis
3.5.1. COVID – 19 recovery analysis
3.6. Major Deals & Strategic Alliances Analysis
Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Large Molecule Bioanalytical Testing Services Market by Phase Outlook
4.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Preclinical
4.5.1.1. Preclinical market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.2. With Antibody
4.5.1.2.1. With Antibody market estimates and forecast 2018 to 2030 (USD Million)
4.5.1.3. Without Antibody ((ELISA Based Assay)
4.5.1.3.1. Without Antibody (ELISA Based Assay) market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Clinical
4.5.2.1. Clinical market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Large Molecule Bioanalytical Testing Services Market by Type Outlook
5.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Pharmacokinetics
5.5.1.1. Pharmacokinetics market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. ADA
5.5.2.1. ADA market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Large Molecule Bioanalytical Testing Services Market by Test Type Outlook
6.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. ADME
6.5.1.1. ADME market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. PD
6.5.2.1. PD market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Bioavailability
6.5.3.1. Bioavailability market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Bioequivalence
6.5.4.1. Bioequivalence market estimates and forecast 2018 to 2030 (USD Million)
6.5.5. Other Tests
6.5.5.1. Other Tests market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Estimates & Trend Analysis
7.1. Definitions and Scope
7.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
7.3. Segment Dashboard
7.4. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Areas Outlook
7.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Oncology
7.5.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
7.5.2. Infectious Diseases
7.5.2.1. Infectious Diseases market estimates and forecast 2018 to 2030 (USD Million)
7.5.3. Cardiology
7.5.3.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million)
7.5.4. Neurology
7.5.4.1. Neurology market estimates and forecast 2018 to 2030 (USD Million)
7.5.5. Others
7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Large Molecule Bioanalytical Testing Services Market by End – user Estimates & Trend Analysis
8.1. Definitions and Scope
8.2. Large Molecule Bioanalytical Testing Services Market Share, 2021 & 2030
8.3. Segment Dashboard
8.4. Global Large Molecule Bioanalytical Testing Services Market by End User Outlook
8.5. Large Molecule Bioanalytical Testing Services Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. SMEs
8.5.1.1. SMEs market estimates and forecast 2018 to 2030 (USD Million)
8.5.1.2. CROs & CMOs
8.5.1.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
8.5.1.3. Sponsor Organizations
8.5.1.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
8.5.1.4. Others
8.5.1.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
8.5.2. Large Firms
8.5.2.1. Large Firms market estimates and forecast 2018 to 2030 (USD Million)
8.5.2.2. CROs & CMOs
8.5.2.2.1. CROs & CMOs market estimates and forecast 2018 to 2030 (USD Million)
8.5.2.3. Sponsor Organizations
8.5.2.3.1. Sponsor Organizations market estimates and forecast 2018 to 2030 (USD Million)
8.5.2.4. Others
8.5.2.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis
9.1. Regional market share analysis, 2021 & 2030
9.2. Regional Market Dashboard
9.3. North America
9.3.1. North America Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.3.2. U.S.
9.3.2.1. U.S. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.3.3. Canada
9.3.3.1. Canada Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.4. Europe
9.4.1. U.K.
9.4.1.1. U.K. Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Germany Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.4.3. France
9.4.3.1. France Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.4.4. Italy
9.4.4.1. Italy Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.4.5. Spain
9.4.5.1. Spain Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Japan Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.5.2. China
9.5.2.1. China Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.5.3. India
9.5.3.1. India Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.5.4. Thailand
9.5.4.1. Thailand Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. South Korea Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Brazil Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.6.2. Mexico
9.6.2.1. Mexico Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Argentina Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.6.4. Colombia
9.6.4.1. Colombia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.7. MEA
9.7.1. South Africa
9.7.1.1. South Africa Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Saudi Arabia Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
9.7.3. UAE
9.7.3.1. UAE Large Molecule Bioanalytical Testing Services Market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. 8.1 Recent Developments & Impact Analysis, By Key Market Participants
10.1.1. Covance
10.1.1.1. Company overview
10.1.1.2. Financial Performance
10.1.1.3. Service benchmarking
10.1.1.4. Strategic initiatives
10.1.2. IQVIA
10.1.2.1. Company overview
10.1.2.2. Financial performance
10.1.2.3. Service benchmarking
10.1.2.4. Strategic initiatives
10.1.3. Syneous Health
10.1.3.1. Company overview
10.1.3.2. Financial performance
10.1.3.3. Service benchmarking
10.1.3.4. Strategic initiatives
10.1.4. SGS, SA
10.1.4.1. Company overview
10.1.4.2. Financial performance
10.1.4.3. Service benchmarking
10.1.4.4. Strategic initiatives
10.1.5. Toxikon
10.1.5.1. Company overview
10.1.5.2. Financial performance
10.1.5.3. Service benchmarking
10.1.5.4. Strategic initiatives
10.1.6. Intertek Plc
10.1.6.1. Company overview
10.1.6.2. Financial performance
10.1.6.3. Service benchmarking
10.1.6.4. Strategic initiatives
10.1.7. Pace Analytical Services LLC
10.1.7.1. Company overview
10.1.7.2. Financial performance
10.1.7.3. Service benchmarking
10.1.7.4. Strategic initiatives
10.1.8. ICON PLC
10.1.8.1. Company overview
10.1.8.2. Financial performance
10.1.8.3. Service benchmarking
10.1.8.4. Strategic initiatives
10.1.9. Charles River Laboratories
10.1.9.1. Company overview
10.1.9.2. Financial performance
10.1.9.3. Service benchmarking
10.1.9.4. Strategic initiatives
10.1.10. ThermoFisher Scientific
10.1.10.1. Company overview
10.1.10.2. Financial performance
10.1.10.3. Service benchmarking
10.1.10.4. Strategic initiatives